Lisanti Capital Growth, LLC Cytokinetics Inc Transaction History
Lisanti Capital Growth, LLC
- $344 Million
- Q3 2024
A detailed history of Lisanti Capital Growth, LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Lisanti Capital Growth, LLC holds 12,355 shares of CYTK stock, worth $620,468. This represents 0.19% of its overall portfolio holdings.
Number of Shares
12,355
Previous 39,155
68.45%
Holding current value
$620,468
Previous $2.12 Million
69.26%
% of portfolio
0.19%
Previous 0.55%
Shares
8 transactions
Others Institutions Holding CYTK
# of Institutions
410Shares Held
125MCall Options Held
4.6MPut Options Held
2.43M-
Black Rock Inc. New York, NY14.7MShares$737 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$591 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.69MShares$487 Million0.31% of portfolio
-
Wellington Management Group LLP Boston, MA7.77MShares$390 Million0.07% of portfolio
-
State Street Corp Boston, MA6.46MShares$324 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.73B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...